期刊文献+

不同方案硝酸咪康唑栓治疗VVC再发的疗效比较

Comparison of effects of miconazolenitrate suppository on recurrent vulvovaginal candidiasis
原文传递
导出
摘要 目的评价硝酸咪康唑1200mg强化治疗及巩固不同疗程治疗外阴阴道念珠菌病(VVC)再发的效果,探讨再发VVC的优化治疗方案。方法采取开放、非对照性临床试验。试验分三组,A组强化治疗,B组在此基础上巩固1个月,C组巩固2个月。对不同疗程患者用药前、用药后7~14d、用药后每个月进行妇科检查、临床症状体征评分、真菌学检查,评估疗效至停药2个月。结果70例患者入选,6例失访,停药2个月时共64例可评价人群。硝酸咪康唑1200mg强化治疗和巩固1~2个疗程的临床治愈率分别为52.4%、52.6%、54.2%;临床总有效率分别为85.7%、94.7%、91.7%;真菌学疗效分别为90.5%、94.7%、95.8%;三组间无统计学差异。结论VVC再发强化治疗效果满意,与巩固1~2疗程治疗疗效相当,增加1~2个疗程不能提高远期疗效和降低复发率。 Objective To evaluate the effects of 1200mg miconazole nitrate intensive treatment and consolidation treatment on recurrent vulvovaginal eandidiasis. Methods An open,non-controlled clinical trial was conducted by allocating the subjects into three groups: group A,intensive treatment; group B, consolidation treatment for one more month than group A; group C, consolidation treatment for two nore than group A. The gynecological examination,clinical signs and symptoms score and mycological examination were conducted monthly. Results A total of 70 patients were enrolled in the trial, among which five lost follow-up and three dropped out in advance during follow-up observation due to being positive in the mycological examination. Sixty-two cases were evaluable two months after drug withdrawal. The clinical cure rates of patients using 1 200 mg mieonazole nitrate intensive treatment and 1-2 courses of consolidation were respectively 55%, 52.6% and 56.5%; the total clinical effective rates were 90% ,94.7% and 95.7%; mycological clearance rates were 90.9%, 94.7% and 95.8%; without showing statistical difference among the three groups. Conclusion The efficacy of intensive treatment on reeurrent vulvovaginal candidiasis is satisfactory.
出处 《中国热带医学》 CAS 2009年第10期1998-1999,共2页 China Tropical Medicine
基金 中华医学会妇产科学会基金资助
关键词 外阴阴道念珠菌病 再发 硝酸咪康唑栓 Vulvovaginal candidiasis Recurrence Miconazole nitrate vaginal ovule
  • 相关文献

参考文献6

二级参考文献26

  • 1刘小平,樊尚荣,李建武.妇科门诊患者外阴阴道念珠菌病的检出率和抗真菌药物敏感性研究[J].中国妇产科临床杂志,2004,5(2):95-98. 被引量:24
  • 2David W, Fleming. Sexually Transmitted Disease Treatment Guidelines 2006 [ J ]. CDC MMWR [ J ], 2006,55 ( RR-11 ) : 54- 56.
  • 3Dan M, Poch F, Levin D. High rate of vaginal infections caused by non-C, albicans candida species among asymptomatic women [J]. Med Mycol,2002,40(4) :383-386.
  • 4Banters TG, Dhont MA, Temmerman MIL. Prevalence of vulvovaginal candidiasis and susceptibility fluconazole in women [ J ]. Am J Obstet Gynecol,2002,187 ( 3 ) :569-574.
  • 5Corsello S,Spinillo A, Osnengo G, et al. An epidemiological survey of vulvovaginal candidiasis in Italy [ J ]. Eur J Obstet Gynecol Reprod Biol,2003,110 ( 1 ) :66-72.
  • 6Ben-Haroush A, Yogev Y, Kaplan B. The importance of diagnostic work-up in the management of candidal vulvovaginitis: a prospective study[ J ]. Clin Exp Obstet Gynecol, 2004,31 ( 2 ) : 113-116.
  • 7Sojakova M, Liptajova D, Borovsky M,et al. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia [ J ]. Mycopathologia,2004,157 (2) : 163-169.
  • 8Perea S, Patterson TF. Antifungal resistance in pathogenic fungi [J]. Clin Infect Dis, 2002,5(9) :1073-1080.
  • 9Walker PP,Reynolds MT,Ashbee HR,et al.Vaginal yeasts in the era of "over the counter" antifungals.Sex Transm Infect,2000,76(6):437-438.
  • 10Fidel PL Jr,Vazquez JA,Sobel JD.Candida glabrata:review of epidemiology,pathogenesis,and clinical disease with comparison to C.albicans.Clin Microbiol Rev,1999,12(1):80-96.

共引文献575

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部